[1] W. Wang, A.C.Y. Lo, Diabetic Retinopathy: Pathophysiology and Treatments, Int J Mol Sci, 19 (2018).
[2] G. Mannino, C. Russo, A. Longo, C.D. Anfuso, G. Lupo, D. Lo Furno, R. Giuffrida, G. Giurdanella, Potential therapeutic applications of mesenchymal stem cells for the treatment of eye diseases, World J Stem Cells, 13 (2021) 632-644.
[3] X. Hu, R. Wu, L.A. Shehadeh, Q. Zhou, C. Jiang, X. Huang, L. Zhang, F. Gao, X. Liu, H. Yu, K.A. Webster, J. Wang, Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells, BMC Genomics, 15 (2014) 303.
[4] P. Page, J. DeJong, A. Bandstra, R.A. Boomsma, Effect of serum and oxygen concentration on gene expression and secretion of paracrine factors by mesenchymal stem cells, Int J Cell Biol, 2014 (2014) 601063.
[5] X. Hu, Y. Xu, Z. Zhong, Y. Wu, J. Zhao, Y. Wang, H. Cheng, M. Kong, F. Zhang, Q. Chen, J. Sun, Q. Li, J. Jin, Q. Li, L. Chen, C. Wang, H. Zhan, Y. Fan, Q. Yang, L. Yu, R. Wu, J. Liang, J. Zhu, Y. Wang, Y. Jin, Y. Lin, F. Yang, L. Jia, W. Zhu, J. Chen, H. Yu, J. Zhang, J. Wang, A Large-Scale Investigation of Hypoxia-Preconditioned Allogeneic Mesenchymal Stem Cells for Myocardial Repair in Nonhuman Primates: Paracrine Activity Without Remuscularization, Circ Res, 118 (2016) 970-983.
[6] J.D. Anderson, H.J. Johansson, C.S. Graham, M. Vesterlund, M.T. Pham, C.S. Bramlett, E.N. Montgomery, M.S. Mellema, R.L. Bardini, Z. Contreras, M. Hoon, G. Bauer, K.D. Fink, B. Fury, K.J. Hendrix, F. Chedin, S. El-Andaloussi, B. Hwang, M.S. Mulligan, J. Lehtio, J.A. Nolta, Comprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling, Stem Cells, 34 (2016) 601-613.
[7] J. Zhu, K. Lu, N. Zhang, Y. Zhao, Q. Ma, J. Shen, Y. Lin, P. Xiang, Y. Tang, X. Hu, J. Chen, W. Zhu, K.A. Webster, J. Wang, H. Yu, Myocardial reparative functions of exosomes from mesenchymal stem cells are enhanced by hypoxia treatment of the cells via transferring microRNA-210 in an nSMase2-dependent way, Artif Cells Nanomed Biotechnol, 46 (2018) 1659-1670.
[8] B.C. Lee, K.S. Kang, Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application, Stem Cell Res Ther, 11 (2020) 397.
[9] N. Ishiuchi, A. Nakashima, S. Doi, K. Yoshida, S. Maeda, R. Kanai, Y. Yamada, T. Ike, T. Doi, Y. Kato, T. Masaki, Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats, Stem Cell Res Ther, 11 (2020) 130.
[10] N.A. Hofmann, A. Ortner, R.O. Jacamo, A. Reinisch, K. Schallmoser, R. Rohban, N. Etchart, M. Fruehwirth, C. Beham-Schmid, M. Andreeff, D. Strunk, Oxygen sensing mesenchymal progenitors promote neo-vasculogenesis in a humanized mouse model in vivo, PLoS One, 7 (2012) e44468.
[11] C.S. Zhang, K. Shao, C.W. Liu, C.J. Li, B.T. Yu, Hypoxic preconditioning BMSCs-exosomes inhibit cardiomyocyte apoptosis after acute myocardial infarction by upregulating microRNA-24, Eur Rev Med Pharmacol Sci, 23 (2019) 6691-6699.
[12] W. Liu, Y. Rong, J. Wang, Z. Zhou, X. Ge, C. Ji, D. Jiang, F. Gong, L. Li, J. Chen, S. Zhao, F. Kong, C. Gu, J. Fan, W. Cai, Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization, J Neuroinflammation, 17 (2020) 47.
[13] W. Liu, L. Li, Y. Rong, D. Qian, J. Chen, Z. Zhou, Y. Luo, D. Jiang, L. Cheng, S. Zhao, F. Kong, J. Wang, Z. Zhou, T. Xu, F. Gong, Y. Huang, C. Gu, X. Zhao, J. Bai, F. Wang, W. Zhao, L. Zhang, X. Li, G. Yin, J. Fan, W. Cai, Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126, Acta Biomater, 103 (2020) 196-212.
[14] F. Gubert, J.S. da Silva, J.F. Vasques, R.G. de Jesus Goncalves, R.S. Martins, M.P.L. de Sa, R. Mendez-Otero, G. Zapata-Sudo, Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases, Int J Mol Sci, 22 (2021).
[15] L.T. Wang, K.J. Liu, H.K. Sytwu, M.L. Yen, B.L. Yen, Advances in mesenchymal stem cell therapy for immune and inflammatory diseases: Use of cell-free products and human pluripotent stem cell-derived mesenchymal stem cells, Stem Cells Transl Med, (2021).
[16] T. Katsuda, N. Kosaka, F. Takeshita, T. Ochiya, The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles, Proteomics, 13 (2013) 1637-1653.
[17] N.P. Hessvik, A. Llorente, Current knowledge on exosome biogenesis and release, Cell Mol Life Sci, 75 (2018) 193-208.
[18] D.G. Phinney, M.F. Pittenger, Concise Review: MSC-Derived Exosomes for Cell-Free Therapy, Stem Cells, 35 (2017) 851-858.
[19] L. Otero-Ortega, F. Laso-Garcia, M. Gomez-de Frutos, B. Fuentes, L. Diekhorst, E. Diez-Tejedor, M. Gutierrez-Fernandez, Role of Exosomes as a Treatment and Potential Biomarker for Stroke, Transl Stroke Res, 10 (2019) 241-249.
[20] N. Ogata, S. Nomura, A. Shouzu, M. Imaizumi, M. Arichi, M. Matsumura, Elevation of monocyte-derived microparticles in patients with diabetic retinopathy, Diabetes Res Clin Pract, 73 (2006) 241-248.
[21] W. Zhang, Y. Wang, Y. Kong, Exosomes Derived From Mesenchymal Stem Cells Modulate miR-126 to Ameliorate Hyperglycemia-Induced Retinal Inflammation Via Targeting HMGB1, Invest Ophthalmol Vis Sci, 60 (2019) 294-303.
[22] A. Safwat, D. Sabry, A. Ragiae, E. Amer, R.H. Mahmoud, R.M. Shamardan, Adipose mesenchymal stem cells-derived exosomes attenuate retina degeneration of streptozotocin-induced diabetes in rabbits, J Circ Biomark, 7 (2018) 1849454418807827.
[23] B. Mead, J. Amaral, S. Tomarev, Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma, Invest Ophthalmol Vis Sci, 59 (2018) 702-714.